DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Sharma P, Rodler E, Barlow WE. et al.
Results of a phase II randomized trial of cisplatin +/− veliparib in metastatic triple-negative breast cancer (TNBC) and/or germline BRCA-associated breast cancer (SWOG S1416).
J Clin Oncol 2020;
38: 1001-1001
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.